Literature DB >> 12383887

Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy.

Muna M Baslaim1, Osama A Al Malik, Saif S Al-Sobhi, Ezzeldin Ibrahim, Adnan Ezzat, Dahish Ajarim, Asma Tulbah, Mohammad A Chaudhary, Ralph A Sorbris.   

Abstract

BACKGROUND: The purpose of this study was to assess our clinical impression that fewer lymph nodes are retrieved after level I and II axillary dissection after neoadjuvant chemotherapy and whether there is a positive correlation between the total number of lymph nodes retrieved and the number of diseased lymph nodes.
METHODS: Patients included those with stage IIB, IIIA, and IIIB breast cancer of whom 77 had neoadjuvant chemotherapy and 58 had initial surgery only. All had modified radical mastectomy with in continuity level I and II axillary dissection.
RESULTS: Patients after neoadjuvant chemotherapy had 14.3 +/- 6.7 lymph nodes detected versus 16.9 +/- 8.8 (mean +/- SD; P <0.057) for those with initial surgery only. The number of positive nodes were 3.7 +/- 4.7 versus 6.6 +/- 8.7 (mean +/- SD; P <0.033) respectively and the number of negative nodes were 10.6 +/- 7.5 versus 10.4 +/- 8 (mean +/- SD; P <0.9). The correlation between the number of positive lymph nodes and the total number of lymph nodes was r = 0.58; P <0.001.
CONCLUSIONS: It appears that fewer lymph nodes are retrieved after level I and II axillary dissection after neoadjuvant chemotherapy. The total number of lymph nodes retrieved increases directly with the number of positive lymph nodes in patients not treated with chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383887     DOI: 10.1016/s0002-9610(02)00959-5

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

1.  Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Authors:  Hassan A Hatoum; Faek R Jamali; Nagi S El-Saghir; Khaled M Musallam; Muhieddine Seoud; Hani Dimassi; Jaber Abbas; Mohamad Khalife; Fouad I Boulos; Ayman N Tawil; Fadi B Geara; Ziad Salem; Achraf A Shamseddine; Karine Al-Feghali; Ali I Shamseddine
Journal:  Indian J Surg Oncol       Date:  2010-08-07

2.  Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.

Authors:  Hassan A Hatoum; Faek R Jamali; Nagi S El-Saghir; Khaled M Musallam; Muhieddine Seoud; Hani Dimassi; Jaber Abbas; Mohamad Khalife; Fouad I Boulos; Ayman N Tawil; Fadi B Geara; Ziad Salem; Achraf A Shamseddine; Karine Al-Feghali; Ali I Shamseddine
Journal:  Indian J Surg Oncol       Date:  2011-03-29

3.  Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status.

Authors:  J E A Somner; J M J Dixon; J S J Thomas
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

4.  Ratios of involved nodes in early breast cancer.

Authors:  Vincent Vinh-Hung; Claire Verschraegen; Donald I Promish; Gábor Cserni; Jan Van de Steene; Patricia Tai; Georges Vlastos; Mia Voordeckers; Guy Storme; Melanie Royce
Journal:  Breast Cancer Res       Date:  2004-10-06       Impact factor: 6.466

5.  Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection.

Authors:  Thalia Erbes; Marzenna Orlowska-Volk; Axel Zur Hausen; Gerta Rücker; Sebastian Mayer; Matthias Voigt; Juliane Farthmann; Severine Iborra; Marc Hirschfeld; Philipp T Meyer; Gerald Gitsch; Elmar Stickeler
Journal:  BMC Cancer       Date:  2014-01-03       Impact factor: 4.430

6.  Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy.

Authors:  San-Gang Wu; Qun Li; Juan Zhou; Jia-Yuan Sun; Feng-Yan Li; Qin Lin; Huan-Xin Lin; Xun-Xing Gaun; Zhen-Yu He
Journal:  Cancer Res Treat       Date:  2014-12-08       Impact factor: 4.679

7.  Lymph Node Ratio (LNR): Predicting Prognosis after Neoadjuvant Chemotherapy (NAC) in Breast Cancer Patients.

Authors:  Atilla Soran; Tolga Ozmen; Arsalan Salamat; Gürsel Soybir; Ronald Johnson
Journal:  Eur J Breast Health       Date:  2019-10-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.